# Lun–Xiu Qin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lun-xiu-qin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,440 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 76 |
| i10-index | 199 |
| Last Known Institution | Fudan University |
| OpenAlex ID | https://openalex.org/A5063254439 |
| ORCID iD | https://orcid.org/0000-0003-4805-8239 |
| Works | 367 |

## Researcher papers

- [Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/atezolizumab-plus-bevacizumab-versus-active-surveillance-in-patients-with/)
- [Lipid metabolism in cancer progression and therapeutic strategies](https://scholariq.org/papers/lipid-metabolism-in-cancer-progression-and-therapeutic-strategies/)
- [The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives](https://scholariq.org/papers/the-molecular-biology-of-pancreatic-adenocarcinoma-translational-challenges-and/)
- [Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma](https://scholariq.org/papers/inhibition-of-egfr-overcomes-acquired-lenvatinib-resistance-driven-by-stat3/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

## Researcher university

- [Fudan University](https://scholariq.org/institutions/fudan-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.